Prophase Labs Inc (PRPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 9,876 | 13,126 | 9,867 | 4,206 | 2,518 |
| Cost of Goods | 7,261 | 8,345 | 7,919 | 3,209 | 1,686 |
| Gross Profit | 2,615 | 4,781 | 1,948 | 997 | 832 |
| Operating Expenses | 6,115 | 6,760 | 6,857 | 5,000 | 3,596 |
| Operating Income | -3,239 | -1,634 | -3,990 | -3,794 | -2,078 |
| Interest Expense | 0 | 0 | 0 | 213 | 18 |
| Other Income | 133 | 167 | 327 | 1 | 2 |
| Pre-tax Income | -3,106 | -1,467 | -3,663 | -4,006 | -2,094 |
| Income Tax | N/A | 103 | -1,421 | N/A | N/A |
| Net Income Continuous | -3,106 | -1,570 | -2,242 | -4,006 | -2,094 |
| Net Income Discontinuous | -40 | -170 | 42,831 | 1,138 | -1,506 |
| Net Income | $-3,146 | $-1,740 | $40,589 | $-2,868 | $-3,600 |
| EPS Basic Total Ops | -0.27 | -0.15 | 2.61 | -0.17 | -0.22 |
| EPS Basic Continuous Ops | -0.27 | -0.14 | -0.14 | -0.24 | -0.13 |
| EPS Basic Discontinuous Ops | 0.00 | -0.01 | 2.75 | 0.07 | -0.09 |
| EPS Diluted Total Ops | -0.27 | -0.15 | 2.59 | -0.17 | -0.22 |
| EPS Diluted Continuous Ops | -0.27 | -0.14 | -0.14 | -0.24 | -0.13 |
| EPS Diluted Discontinuous Ops | 0.00 | -0.01 | 2.73 | 0.07 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -0.27 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-2,841 | $-1,251 | $-3,643 | $-3,344 | $-1,711 |